Artificial Lung Market By Artificial Lung Type (Oxygenation-Based Artificial Lungs {ECMO Systems, Implantable Oxygenation Devices}, Bioengineered Lungs {Stem Cell-Based, Tissue-Engineered}, 3D-Printed Lungs {Bioprinted, Custom 3D-Printed Prosthetics}), By Application (COPD, ARDS, Lung Transplantation, Pulmonary Hypertension, COVID-19 & Respiratory Failure, Cystic Fibrosis & Genetic Disorders, Other), By Technology (Mechanical Ventilation, Biological Oxygenation Systems, Hybrid Systems), By End-User (Hospitals & ICUs, Specialty Clinics & Lung Transplant Centers, Research & Academic Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles, And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Artificial Lung Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Rising prevalence of respiratory diseases like COPD, ARDS, and pulmonary hypertension

3.2.2. Increased Investment in Bioengineered & Stem Cell-Based Lungs

3.2.3. Innovations in biomaterials, microfluidics, and nanotechnology enhance artificial lung designs

3.3. Key industry pitfalls & challenges

3.3.1. High costs associated with artificial lung devices and procedures

3.3.2. Stringent regulatory requirements delay product approvals and market entry

3.3.3. Concerns regarding artificial organ implantation and bioethical issues may limit adoption

3.4. Market Opportunities

3.4.1. Innovations in miniaturized and implantable devices present future growth potential

3.4.2. Development of portable and wearable artificial lung devices for enhanced mobility

3.4.3. Partnerships can accelerate advancements and commercialization of artificial lung technologies

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Artificial Lung Market, Artificial Lung Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Artificial Lung Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Oxygenation-Based Artificial Lungs

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.2. Extracorporeal Membrane Oxygenation (ECMO) Systems

4.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.3. Implantable Oxygenation Devices

4.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Bioengineered Lungs

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.2. Stem Cell-Based Lungs

4.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.3. Tissue-Engineered Lungs

4.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. 3D-Printed Lungs

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.2. Bioprinted Lungs

4.4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.3. Custom 3D-Printed Prosthetic Lungs

4.4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Artificial Lung Market, Application Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Application, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Chronic Obstructive Pulmonary Disease (COPD)

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Acute Respiratory Distress Syndrome (ARDS)

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Lung Transplantation

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Pulmonary Hypertension

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. COVID-19 and Respiratory Failure

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.7. Cystic Fibrosis and Other Genetic Lung Disorders

5.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.8. Other

5.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Artificial Lung Market, Technology Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By End-User, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Mechanical Ventilation

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Biological Oxygenation Systems

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Hybrid Systems

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Artificial Lung Market, End-User Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By End-User, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Hospitals & Intensive Care Units (ICUs)

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Specialty Clinics & Lung Transplant Centers

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Research & Academic Institutions

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Artificial Lung Market, Region Segment Analysis

8.1. Overview

8.1.1. Global Market Revenue Share, By Region, 2025 & 2035

8.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)

8.2. North America

8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)

8.2.2. North America Market Revenue, By Artificial Lung Type, 2025-2035

8.2.3. North America Market Revenue, By Application, 2025-2035

8.2.4. North America Market Revenue, By Technology, 2025-2035

8.2.5. North America Market Revenue, By End-User, 2025-2035

8.2.6. The U.S.

8.2.6.1. U.S. Market Revenue, By Artificial Lung Type, 2025-2035

8.2.6.2. U.S. Market Revenue, By Application, 2025-2035

8.2.6.3. U.S. Market Revenue, By Technology, 2025-2035

8.2.6.4. U.S. Market Revenue, By End-User, 2025-2035

8.2.7. Canada

8.2.7.1. Canada Market Revenue, By Artificial Lung Type, 2025-2035

8.2.7.2. Canada Market Revenue, By Application, 2025-2035

8.2.7.3. Canada Market Revenue, By Technology, 2025-2035

8.2.7.4. Canada Market Revenue, By End-User, 2025-2035

8.3. Europe

8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)

8.3.2. Europe Market Revenue, By Artificial Lung Type, 2025-2035

8.3.3. Europe Market Revenue, By Application, 2025-2035

8.3.4. Europe Market Revenue, By Technology, 2025-2035

8.3.5. Europe Market Revenue, By End-User, 2025-2035

8.3.6. Germany

8.3.6.1. Germany Market Revenue, By Artificial Lung Type, 2025-2035

8.3.6.2. Germany Market Revenue, By Application, 2025-2035

8.3.6.3. Germany Market Revenue, By Technology, 2025-2035

8.3.6.4. Germany Market Revenue, By End-User, 2025-2035

8.3.7. France

8.3.7.1. France Market Revenue, By Artificial Lung Type, 2025-2035

8.3.7.2. France Market Revenue, By Application, 2025-2035

8.3.7.3. France Market Revenue, By Technology, 2025-2035

8.3.7.4. France Market Revenue, By End-User, 2025-2035

8.3.8. U.K.

8.3.8.1. U.K. Market Revenue, By Artificial Lung Type, 2025-2035

8.3.8.2. U.K. Market Revenue, By Application, 2025-2035

8.3.8.3. U.K. Market Revenue, By Technology, 2025-2035

8.3.8.4. U.K. Market Revenue, By End-User, 2025-2035

8.3.9. Italy

8.3.9.1. Italy Market Revenue, By Artificial Lung Type, 2025-2035

8.3.9.2. Italy Market Revenue, By Application, 2025-2035

8.3.9.3. Italy Market Revenue, By Technology, 2025-2035

8.3.9.4. Italy Market Revenue, By End-User, 2025-2035

8.3.10. Spain

8.3.10.1. Spain Market Revenue, By Artificial Lung Type, 2025-2035

8.3.10.2. Spain Market Revenue, By Application, 2025-2035

8.3.10.3. Spain Market Revenue, By Technology, 2025-2035

8.3.10.4. Spain Market Revenue, By End-User, 2025-2035

8.3.11. Rest of Europe

8.3.11.1. Rest of Europe Market Revenue, By Artificial Lung Type, 2025-2035

8.3.11.2. Rest of Europe Market Revenue, By Application, 2025-2035

8.3.11.3. Rest of Europe Market Revenue, By Technology, 2025-2035

8.3.11.4. Rest of Europe Market Revenue, By End-User, 2025-2035

8.4. Asia Pacific

8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)

8.4.2. Asia Pacific Market Revenue, By Artificial Lung Type, 2025-2035

8.4.3. Asia Pacific Market Revenue, By Application, 2025-2035

8.4.4. Asia Pacific Market Revenue, By Technology, 2025-2035

8.4.5. Asia Pacific Market Revenue, By End-User, 2025-2035

8.4.6. China

8.4.6.1. China Market Revenue, By Artificial Lung Type, 2025-2035

8.4.6.2. China Market Revenue, By Application, 2025-2035

8.4.6.3. China Market Revenue, By Technology, 2025-2035

8.4.6.4. China Market Revenue, By End-User, 2025-2035

8.4.7. Japan

8.4.7.1. Japan Market Revenue, By Artificial Lung Type, 2025-2035

8.4.7.2. Japan Market Revenue, By Application, 2025-2035

8.4.7.3. Japan Market Revenue, By Technology, 2025-2035

8.4.7.4. Japan Market Revenue, By End-User, 2025-2035

8.4.8. India

8.4.8.1. India Market Revenue, By Artificial Lung Type, 2025-2035

8.4.8.2. India Market Revenue, By Application, 2025-2035

8.4.8.3. India Market Revenue, By Technology, 2025-2035

8.4.8.4. India Market Revenue, By End-User, 2025-2035

8.4.9. Australia

8.4.9.1. Australia Market Revenue, By Artificial Lung Type, 2025-2035

8.4.9.2. Australia Market Revenue, By Application, 2025-2035

8.4.9.3. Australia Market Revenue, By Technology, 2025-2035

8.4.9.4. Australia Market Revenue, By End-User, 2025-2035

8.4.10. South Korea

8.4.10.1. South Korea Market Revenue, By Artificial Lung Type, 2025-2035

8.4.10.2. South Korea Market Revenue, By Application, 2025-2035

8.4.10.3. South Korea Market Revenue, By Technology, 2025-2035

8.4.10.4. South Korea Market Revenue, By End-User, 2025-2035

8.4.11. Singapore

8.4.11.1. Singapore Market Revenue, By Artificial Lung Type, 2025-2035

8.4.11.2. Singapore Market Revenue, By Application, 2025-2035

8.4.11.3. Singapore Market Revenue, By Technology, 2025-2035

8.4.11.4. Singapore Market Revenue, By End-User, 2025-2035

8.4.12. Rest of Asia Pacific

8.4.12.1. Rest of Asia Pacific Market Revenue, By Artificial Lung Type, 2025-2035

8.4.12.2. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

8.4.12.3. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

8.4.12.4. Rest of Asia Pacific Market Revenue, By End-User, 2025-2035

8.5. Latin America

8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)

8.5.2. Latin America Market Revenue, By Artificial Lung Type, 2025-2035

8.5.3. Latin America Market Revenue, By Application, 2025-2035

8.5.4. Latin America Market Revenue, By Technology, 2025-2035

8.5.5. Latin America Market Revenue, By End-User, 2025-2035

8.5.6. Brazil

8.5.6.1. Brazil Market Revenue, By Artificial Lung Type, 2025-2035

8.5.6.2. Brazil Market Revenue, By Application, 2025-2035

8.5.6.3. Brazil Market Revenue, By Technology, 2025-2035

8.5.6.4. Brazil Market Revenue, By End-User, 2025-2035

8.5.7. Argentina

8.5.7.1. Argentina Market Revenue, By Artificial Lung Type, 2025-2035

8.5.7.2. Argentina Market Revenue, By Application, 2025-2035

8.5.7.3. Argentina Market Revenue, By Technology, 2025-2035

8.5.7.4. Argentina Market Revenue, By End-User, 2025-2035

8.5.8. Mexico

8.5.8.1. Mexico Market Revenue, By Artificial Lung Type, 2025-2035

8.5.8.2. Mexico Market Revenue, By Application, 2025-2035

8.5.8.3. Mexico Market Revenue, By Technology, 2025-2035

8.5.8.4. Mexico Market Revenue, By End-User, 2025-2035

8.5.9. Rest of Latin America

8.5.9.1. Rest of Latin America Market Revenue, By Artificial Lung Type, 2025-2035

8.5.9.2. Rest of Latin America Market Revenue, By Application, 2025-2035

8.5.9.3. Rest of Latin America Market Revenue, By Technology, 2025-2035

8.5.9.4. Rest of Latin America Market Revenue, By End-User, 2025-2035

8.6. MEA

8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)

8.6.2. MEA Market Revenue, By Artificial Lung Type, 2025-2035

8.6.3. MEA Market Revenue, By Application, 2025-2035

8.6.4. MEA Market Revenue, By Technology, 2025-2035

8.6.5. MEA Market Revenue, By End-User, 2025-2035

8.6.6. GCC Countries

8.6.6.1. GCC Countries Market Revenue, By Artificial Lung Type, 2025-2035

8.6.6.2. GCC Countries Market Revenue, By Application, 2025-2035

8.6.6.3. GCC Countries Market Revenue, By Technology, 2025-2035

8.6.6.4. GCC Countries Market Revenue, By End-User, 2025-2035

8.6.7. South Africa

8.6.7.1. South Africa Market Revenue, By Artificial Lung Type, 2025-2035

8.6.7.2. South Africa Market Revenue, By Application, 2025-2035

8.6.7.3. South Africa Market Revenue, By Technology, 2025-2035

8.6.7.4. South Africa Market Revenue, By End-User, 2025-2035

8.6.8. Rest of Middle-East & Africa

8.6.8.1. Rest of Middle-East & Africa Market Revenue, By Artificial Lung Type, 2025-2035

8.6.8.2. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

8.6.8.3. Rest of Middle-East & Africa Market Revenue, By Technology, 2025-2035

8.6.8.4. Rest of Middle-East & Africa Market Revenue, By End-User, 2025-2035

9. Company Profile

9.1. ALung Technologies

9.1.1. Business Overview

9.1.2. Financial Performance

9.1.3. Product/Service Offerings

9.1.4. Strategies & recent developments

9.1.5. SWOT Analysis

9.2. Breethe

9.2.1. Business Overview

9.2.2. Financial Performance

9.2.3. Product/Service Offerings

9.2.4. Strategies & recent developments

9.2.5. SWOT Analysis

9.3. Haemair

9.3.1. Business Overview

9.3.2. Financial Performance

9.3.3. Product/Service Offerings

9.3.4. Strategies & recent developments

9.3.5. SWOT Analysis

9.4. Lung Biotechnology PBC

9.4.1. Business Overview

9.4.2. Financial Performance

9.4.3. Product/Service Offerings

9.4.4. Strategies & recent developments

9.4.5. SWOT Analysis

9.5. McGowan Institute for Regenerative Medicine

9.5.1. Business Overview

9.5.2. Financial Performance

9.5.3. Product/Service Offerings

9.5.4. Strategies & recent developments

9.5.5. SWOT Analysis

9.6. MedArray Inc

9.6.1. Business Overview

9.6.2. Financial Performance

9.6.3. Product/Service Offerings

9.6.4. Strategies & recent developments

9.6.5. SWOT Analysis

9.7. Michigan Critical Care Consultants, Inc

9.7.1. Business Overview

9.7.2. Financial Performance

9.7.3. Product/Service Offerings

9.7.4. Strategies & recent developments

9.7.5. SWOT Analysis

9.8. Miromatrix Medical Inc.

9.8.1. Business Overview

9.8.2. Financial Performance

9.8.3. Product/Service Offerings

9.8.4. Strategies & recent developments

9.8.5. SWOT Analysis

9.9. Draper

9.9.1. Business Overview

9.9.2. Financial Performance

9.9.3. Product/Service Offerings

9.9.4. Strategies & recent developments

9.9.5. SWOT Analysis

9.10. Xenios AG

9.10.1. Business Overview

9.10.2. Financial Performance

9.10.3. Product/Service Offerings

9.10.4. Strategies & recent developments

9.10.5. SWOT Analysis

9.11. Medtronic Inc.

9.11.1. Business Overview

9.11.2. Financial Performance

9.11.3. Product/Service Offerings

9.11.4. Strategies & recent developments

9.11.5. SWOT Analysis

9.12. LivaNova PLC

9.12.1. Business Overview

9.12.2. Financial Performance

9.12.3. Product/Service Offerings

9.12.4. Strategies & recent developments

9.12.5. SWOT Analysis

9.13. MAQUET GmbH & Co KG

9.13.1. Business Overview

9.13.2. Financial Performance

9.13.3. Product/Service Offerings

9.13.4. Strategies & recent developments

9.13.5. SWOT Analysis

9.14. Terumo Corporation

9.14.1. Business Overview

9.14.2. Financial Performance

9.14.3. Product/Service Offerings

9.14.4. Strategies & recent developments

9.14.5. SWOT Analysis

9.15. C.R. Bard Inc.

9.15.1. Business Overview

9.15.2. Financial Performance

9.15.3. Product/Service Offerings

9.15.4. Strategies & recent developments

9.15.5. SWOT Analysis